Weight regain after discontinuing GLP-1 medications is a documented concern for both drugs
doi: 10.3389/fendo.2024.1379228 Received 30 January 2024 Accepted 08 April 2024 Published 30 April 2024 Volume 15 - 2024 Edited by Fabrizio Barbetti, University of Rome Tor Vergata, Italy Reviewed by Xavier Prieur, INSERM U1087 Institut du Thorax, France Joseph Polex-Wolf, Novo Nordisk, Denmark Updates Copyright 2024 Roumane, Mcilroy, Sommer, Han, Heisler and Rochford
[DOI] [PMC free article] [PubMed] [Google Scholar] Shin J, Song MH, Oh JW, Keum YS, Saini RK
[34]Location in patent: experimental part Liebeskind, Sonja
Median child care costs are passing $12,000 per year in Kentucky counties
The two most common other GLP-1 RA medications are liraglutide (which includes Saxenda and Victoza) and Tirzepatide (which includes Mounjaro and Zepbound)